Calcinosis: Clinical Trials

7 trials for Calcinosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Unknown 7

Follow Calcinosis: new trials by email Literature Review of Calcinosis trials Research Report on Calcinosis

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients
palicalcitol - Chronic Kidney Disease-Mineral and Bone Disorder
Phase 4UnknownXiaoyan Jia802023-04-012024-03-08
Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis
Cholecalciferol, Placebo - Vitamin D Deficiency, Vascular Calcification
Phase 4UnknownInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran582015-10-012017-03-24
Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2
Calcitriol, placebo - Chronic Kidney Disease Stage 1, Chronic Kidney Disease Stage 2
Phase 4UnknownTaixing People's Hospital3002015-07-012015-06-08
Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
Lanthanum carbonate, Calcium Carbonate - Renal Insufficiency, Chronic, Hyperphosphatemia
Phase 4UnknownOsaka University602014-09-012021-02-25
Optimizing Treatment Programs for Chronic Kidney Disease-mineral and Bone Disorder and Malnutrition
1,25(OH)2 Vitamin D3, Vitamin D2, low protein diet - Vitamin D Deficiency, Malnutrition
Phase 4UnknownWenhu Liu6002013-01-012013-12-09
Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
alendronate (Fosamax) - Peritoneal Dialysis
Phase 4UnknownFar Eastern Memorial Hospital502006-03-012006-03-07
Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients
pioglitazone - Coronary Atherosclerosis, Inflammation
Phase 4UnknownNational Taiwan University Hospital1202004-11-012006-02-27

Narrower conditions

Vascular Calcification (5)  ·  Renal Insufficiency, Chronic (3)  ·  Vitamin D Deficiency (2)  ·  Atherosclerosis (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Chronic Kidney Disease-Mineral and Bone Disorder (1)  ·  Coronary Artery Disease (1)  ·  Coronary Disease (1)  ·  Hyperphosphatemia (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Malnutrition (1)  ·  Plaque, Amyloid (1)

Broader conditions

Calcium Metabolism Disorders (7)  ·  Metabolic Diseases (7)  ·  Nutritional and Metabolic Diseases (7)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Kidney Diseases (5)  ·  Male Urogenital Diseases (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Urogenital Diseases (5)  ·  Urologic Diseases (5)  ·  Chronic Disease (4)  ·  Disease Attributes (4)  ·  Avitaminosis (3)

Interventions

Calcitriol (2)  ·  Alendronate (1)  ·  Calcium Carbonate (1)  ·  Cholecalciferol (1)  ·  Diet, Protein-Restricted (1)  ·  Ergocalciferols (1)  ·  Pioglitazone (1)  ·  lanthanum carbonate (1)

Sponsors

Far Eastern Memorial Hospital (1)  ·  Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1)  ·  National Taiwan University Hospital (1)  ·  Osaka University (1)  ·  Taixing People's Hospital (1)  ·  Wenhu Liu (1)  ·  Xiaoyan Jia (1)

Countries

China (3)  ·  Taiwan (2)  ·  Japan (1)  ·  Mexico (1)

Top investigators

Chun-Fu Lai, M.D. (1)  ·  Ricardo Correa-Rotter, MD (1)  ·  Takayuki Hamano, MD, PhD (1)  ·  Tzung-Dau Wang, MD, PhD (1)  ·  Wenhu Liu, Doctor (1)

Results publications

PMID 17468488, PMID 19007931, PMID 23535831, PMID 25770176, PMID 26293840, PMID 34231877